Royal Bank Of Canada Lucira Health, Inc. Transaction History

Royal Bank Of Canada

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.11 - $0.83 $15 - $119	-144 Reduced 1.22%	11,660 $1,000
Q3 2022 Nov 14, 2022	BUY	$1.27 - $3.39 $182 - $488	144 Added 1.23%	11,804 $12,000
Q3 2021 Nov 15, 2021	BUY	$6.05 - $10.81 $66,543 - $118,899	10,999 Added 1663.99%	11,660 $89,000
Q2 2021 Aug 16, 2021	BUY	$4.56 - $11.45 $3,014 - $7,568	661 New	661 $4,000

Ticker LHDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 40,106,500
Market Cap $1.2M
Description
Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a paten...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.